APOE and atherosclerosis: Matsubara et al studied the effects of the DPP-4i sitagliptin on atherosclerosis in mice,92 demonstrating the reduction of atherosclerotic lesions, improved endothelial function, and reduced infiltration of CD68+ cells into the vascular wall and expression levels of cytokines in ApoE−/− mice (Fig. 5).92